Rectal adenocarcinoma: Results of adjuvant chemotherapy in a retrospective cohort.

被引:0
|
作者
Reguera Puertas, Pablo
Pachon Olmos, Vanessa
Ferreiro Monteagudo, Reyes
Longo, Federico
Guillen Ponce, Carmen
Vaz Salgado, Maria Angeles
Rodriguez Garrote, Mercedes
Gion Cortes, Maria
Madariaga Urrutia, Ainhoa
Cortes Salgado, Alfonso
Cortez Castedo, Silvia Patricia
Munoz del Toro, Jacobo
Earl, Julie
Hervas Moron, Asuncion
Fernandez Lizarbe, Eva
Sempere Ortega, Cayetano
Die Trill, Javier
Rey Ibarra, Antonio
Carrato, Alfredo
机构
[1] Ramon y Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain
[2] Ramon y Cajal Univ Hosp, Dept Med Oncol, IRYCIS, Madrid, Spain
[3] Ramon y Cajal Univ Hosp, Dept Radiat Oncol, Madrid, Spain
[4] Ramon y Cajal Univ Hosp, Dept Radiol, Madrid, Spain
[5] Ramon y Cajal Univ Hosp, Dept Gen Surg, Madrid, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14539
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Is There a Role for Adjuvant Chemotherapy in Rectal Cancer?
    Prolla, Gabriel
    CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (02) : 70 - 77
  • [32] Chemoradiotherapy and adjuvant chemotherapy for rectal cancer
    Watanabe, Toshiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (06) : 488 - 497
  • [33] Adjuvant chemotherapy for rectal cancer - Reply
    Gray, Richard
    McConkey, Chris
    LANCET, 2008, 371 (9623): : 1503 - 1503
  • [34] Adjuvant chemotherapy for rectal cancer Reply
    Bosset, Jean-Francois
    Collette, Laurence
    LANCET ONCOLOGY, 2014, 15 (06): : E197 - E198
  • [35] Adjuvant chemotherapy for patients with rectal cancer?
    Breugom, Anne J.
    van de Velde, Cornelis J. H.
    LANCET ONCOLOGY, 2014, 15 (11): : 1185 - 1186
  • [36] Impact on survival of adjuvant chemotherapy following chemoradiotherapy and surgery in locally advanced, non -metastatic rectal adenocarcinoma: a retrospective analysis among 331 patients
    Sondaq, M.
    Tambou, M. Nguimpi
    Schumacher, C.
    Reimund, J.
    Serfaty, L.
    Duclos, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study
    Samer A. Naffouje
    Yuen-Joyce Liu
    Sivesh K. Kamarajah
    George I. Salti
    Fadi Dahdaleh
    International Journal of Colorectal Disease, 2022, 37 : 2137 - 2148
  • [38] Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study
    Naffouje, Samer A.
    Liu, Yuen-Joyce
    Kamarajah, Sivesh K.
    Salti, George, I
    Dahdaleh, Fadi
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (10) : 2137 - 2148
  • [39] The effect of time to adjuvant chemotherapy on survival in nonmetastatic resectable pancreatic adenocarcinoma: A retrospective analysis
    Pisa, A.
    Pericay, C.
    Dotor, E.
    Alfaro, J.
    Orellana, R.
    Pujal, M.
    Amador, M. A.
    Garcia Borobia, F.
    Mato, R.
    Saigi, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] A comparison of the outcomes after neoadjuvant (NC) or adjuvant chemotherapy (AC) for muscle-invasive urothelial bladder cancer (UC): A French contemporary retrospective multicenter cohort.
    Pouessel, Damien
    Chevret, Sylvie
    Roubaud, Guilhem
    Aarab-Terrisse, Safae
    Chevreau, Christine
    Vordos, Dimitri
    Rolland, Frederic
    Boudin, Laurys
    Joly, Florence
    Joly, Charlotte
    Beuzeboc, Philippe
    Boyle, Helen Jane
    Farneti, Delphine
    Dauba, Jerome
    Moriceau, Guillaume
    Alexandre, Ingrid
    Deplanque, Gael
    Loriot, Yohann
    Houede, Nadine
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)